NCT06110754

Brief Summary

This study develops and tests the feasibility and acceptability of an adapted intervention, Integrative Strong Body and Mind Training (I-STRONG), in adolescents with pain from sickle cell disease.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2023

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 8, 2023

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

October 26, 2023

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 1, 2023

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 14, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 14, 2024

Completed
1.5 years until next milestone

Results Posted

Study results publicly available

December 19, 2025

Completed
Last Updated

December 19, 2025

Status Verified

December 1, 2025

Enrollment Period

1 year

First QC Date

October 26, 2023

Results QC Date

June 13, 2025

Last Update Submit

December 3, 2025

Conditions

Keywords

Sickle cell painPediatricsMind-body interventionBehavioral intervention

Outcome Measures

Primary Outcomes (1)

  • Brief Pain Inventory (BPI) Pain Severity Score

    Pain intensity is rated with the pain severity item of the Brief Pain Inventory (BPI). The single item is scored on a scale from 0 to 10 where no pain = 0 and severe pain = 10.

    Baseline, Post-treatment (Week 8), 3 Months Post-treatment (Month 5)

Secondary Outcomes (11)

  • Brief Pain Inventory (BPI) Pain Interference Score

    Baseline, Post-treatment (Week 8), 3 Months Post-treatment (Month 5)

  • Patient Health Questionnaire (PHQ-8) Score

    Baseline, Post-treatment (Week 8), 3 Months Post-treatment (Month 5)

  • General Anxiety Disorder (GAD-2) Score

    Baseline, Post-treatment (Week 8), 3 Months Post-treatment (Month 5)

  • Pain Catastrophizing Scale Score

    Baseline, Post-treatment (Week 8), 3 Months Post-Treatment (Month 5)

  • Pediatric Quality of Life Inventory (PedsQL) Score

    Baseline, Post-treatment (Week 8), 3 Months Post-treatment (Month 5)

  • +6 more secondary outcomes

Study Arms (2)

Development of I-STRONG for SCD

NO INTERVENTION

Adolescents with sickle cell disease and their parents participating completing in-depth interviews over two sessions as part of adapting an integrative, multicomponent, behavioral intervention combining mind-body, cognitive, and behavioral coping skills with neuromuscular exercise training for adolescents with chronic SCD pain.

I-STRONG for SCD

EXPERIMENTAL

Adolescents with sickle cell disease and their parents participating in a multi-component intervention that includes mind-body, cognitive-behavioral, and neuromuscular movement training.

Behavioral: I-STRONG for SCD

Interventions

I-STRONG for SCD is a group-based, multi-component intervention that includes mind-body, cognitive-behavioral, and neuromuscular movement training. The intervention includes 16 sessions that occur over 8 weeks. Adolescents attend every session and parents attend 6 of the 16 sessions.

I-STRONG for SCD

Eligibility Criteria

Age12 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Diagnosed with SCD (any genotype)
  • Score of at least 3 (indicating medium to high risk for chronic pain) on the Pediatric Pain Screening Tool
  • Stable disease-modifying treatments, if applicable, as defined by no newly initiated or significantly increased dosages (mg/kg) in the past 3 months (Aim 2 only)
  • English fluency (Aim 2 only)

You may not qualify if:

  • Comorbid medical conditions typically associated with pain but unrelated to SCD (e.g., rheumatologic disorders or inflammatory bowel disease)
  • Presence of a condition(s) or diagnosis, either physical or psychological, or physical exam finding that precludes participation (e.g., severe avascular necrosis with limited or non-weight bearing restrictions, significant cognitive or developmental limitations, active suicidal ideation) (Aim 2 only)
  • Adolescent receiving active treatment (e.g., weekly appointments with a provider) for nonpharmacological therapies (e.g, structured behavioral pain management, physical therapy, or acupuncture program) that overlap with the active phase of the study intervention (Aim 2 only)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Children's Healthcare of Atlanta (CHOA)

Atlanta, Georgia, 30322, United States

Location

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, 45229, United States

Location

Related Publications (1)

  • Mooney JT, Sinha C, Bakshi N, Nunez A, Adkins T, Thomas S, Beasley K, Akintobi T, Crosby L, Kashikar-Zuck S, Dampier C, Myer GD, Kesar T, Quinn CT, Sil S. Physical activity among adolescents and young adults living with chronic pain and sickle cell disease: a qualitative examination. J Pediatr Psychol. 2025 Dec 1;50(12):1079-1087. doi: 10.1093/jpepsy/jsaf055.

MeSH Terms

Conditions

Anemia, Sickle Cell

Condition Hierarchy (Ancestors)

Anemia, Hemolytic, CongenitalAnemia, HemolyticAnemiaHematologic DiseasesHemic and Lymphatic DiseasesHemoglobinopathiesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Results Point of Contact

Title
Soumitri Sil, PhD
Organization
Emory University

Study Officials

  • Soumitri Sil, PhD

    Emory University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Model Details: Participants in Aim 1 provide feedback for adapting I-STRONG for SCD while participants in Aim 2 receive the I-STRONG for SCD intervention.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

October 26, 2023

First Posted

November 1, 2023

Study Start

June 8, 2023

Primary Completion

June 14, 2024

Study Completion

June 14, 2024

Last Updated

December 19, 2025

Results First Posted

December 19, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will share

Deidentified individual participant data will be available for sharing including study-level metadata and NIH Helping to End Addiction Long-term (HEAL) Common Data Elements.

Time Frame
Data will be available for sharing one year after the end date for this study.
Access Criteria
Data for sharing will be in a public use, NIH HEAL-approved data repository.

Locations